Access to quality clinical trials advances oncology science and provides cancer patients promising new therapies and enhanced quality cancer treatment. Oncology clinical trials may measure the efficacy and safety of medical devices, treatment regimens, new pharmaceutical drugs and drug combinations. They often define new standards of care. The American Society of Clinical ... Continue Reading

Another new clinical trial, led by Dr. Henderson is the TRIST (TroVax Renal Immunotherapy Survival Trial), an international, Phase III clinical trial of Oxford BioMedica's therapeutic cancer vaccine, TroVax, in kidney (renal) cancer. Dr. Henderson seeks to determine whether TroVax, a type of immunotherapy, when added to first line standard of care therapy, improves survival ... Continue Reading

Piedmont Hospital's Charles Henderson, M.D. , along with six other major liver cancer treatment centers around the country, is involved in a Phase II trial of the organic arsenic-based drug darinaparsin (Z10-101). Darinaparsin, made by Ziopharm, is an organic compound. Administered intravenously, it causes cancer cells to die by targeting several cellular pathways essential ... Continue Reading